Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 7154, Suchdauer: 1.04s

12 3 4 5 6 7 8 9 10 11 weiter »

1
Lymphoma patients treated with anti-CD20 and chemotherapy display disconnected T and B cell responses to COVID-19 vaccine

von Sylvain Lamure ; Houria Hendel Chavez ; Marie-Ghislaine de Goër de Herve ; et al.

Frontiers in Immunology, Vol 15 (2025)

Schlagworte: COVID-19 vaccine; lymphoma; immune response; anti-CD20; chemotherapy; Immunologic diseases. Allergy; RC581-607
- View full text via DOI
Merkliste

2
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings

von Giuseppe Rossi ; Jon Salmanton-García ; Chiara Cattaneo ; et al.

International Journal of Infectious Diseases, Vol 137, Iss , Pp 98-110 (2023)

Schlagworte: Elderly; SARS-CoV-2; Hematological malignancy; High-risk patient; COVID-19; Infectious and parasitic diseases; RC109-216
- View full text via DOI
Merkliste

3
Human immunodeficiency virus‐associated Lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up

von Kai Hübel ; Mark Bower ; Igor Aurer ; et al.

HemaSphere, Vol 8, Iss 9, Pp n/a-n/a (2024)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

4
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022Research in context

von Jon Salmanton-García ; Francesco Marchesi ; Francesca Farina ; et al.

EClinicalMedicine, Vol 71, Iss , Pp 102553- (2024)

Schlagworte: Vaccination; ICU; COVID-19; Haematological malignancy; Immunosuppression; Medicine (General); R5-920
- View full text via DOI
Merkliste

5
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry

von Francesco Marchesi ; Jon Salmanton-García ; Caterina Buquicchio ; et al.

Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-5 (2023)

Schlagworte: COVID-19; Passive immunization; Tixagevimab/cilgavimab; Hematologic malignancies; Diseases of the blood and blood-forming organs; RC633-647.5; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

6
Intake of total, classes, and subclasses of (poly)phenols and risk of lymphoid neoplasms: a prospective analysis in the EPIC cohort

von Almanza-Aguilera, Enrique ; Guananga-Álvarez, David ; Benavente, Yolanda ; et al.

British Journal of Cancer. 133(12):1864-1871
- Zum Volltext (via ReDI)
Merkliste

7
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry

von Tommaso Francesco Aiello ; Jon Salmanton-Garcia ; Francesco Marchesi ; et al.

Haematologica, Vol 999, Iss 1 (2024)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

8
CCNF (Cyclin F) as a Candidate Gene for Familial Hodgkin Lymphoma: Additional Evidence for the Importance of Mitotic Checkpoint Defects in Tumorigenesis

von Elsa Khoury ; Hiba Maalouf ; Antonella Mendola ; et al.

HemaSphere, Vol 7, Iss 12, p e985 (2023)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

9
P1521: IMPROVED CLINICAL OUTCOME OF COVID-19 IN HAEMATOLOGIC MALIGNANCY PATIENTS RECEIVING A FOURTH DOSE OF ANTI-SARS-COV-2 VACCINE: AN EPICOVIDEHA REPORT

von Jon Salmanton-García ; Francesco Marchesi ; Andreas Glenthøj ; et al.

HemaSphere, Vol 7, p e65137d1 (2023)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

10
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

von Livio Pagano ; Jon Salmanton-García ; Francesco Marchesi ; et al.

Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-15 (2021)

Schlagworte: COVID-19; Pandemic; Hematological malignancies; Epidemiology; EHA; Diseases of the blood and blood-forming organs; RC633-647.5; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

11
S292: NIRMATRELVIR/RITONAVIR IN COVID-19 PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: A REPORT FROMTHE EPICOVIDEHA REGISTRY

von Jon Salmanton-García ; Francesco Marchesi ; Maria Gomes Da Silva ; et al.

HemaSphere, Vol 7, p e61947d1 (2023)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

12
PB2586: PASSIVE PREEXPOSURE IMMUNIZATION BY TIXAGEVIMAB/CILGAVIMAB IN COVID 19 INFECTED HEMATOLOGICAL MALIGNANCY OF EPICOVIDHEA SURVEY

von Caterina Buquicchio ; Jon Salmanton-García ; Francesco Marchesi ; et al.

HemaSphere, Vol 7, p e4500369 (2023)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

13
PD-L1+ plasma cells suppress T lymphocyte responses in patients with sepsis and mouse sepsis models

von Gossez, Morgane ; Vigneron, Clara ; Vandermoeten, Alexandra ; et al.

Nature Communications. 16(1)
- Zum Volltext in PubMed Central
Merkliste

14
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registryResearch in context

von Jon Salmanton-García ; Francesco Marchesi ; Maria Gomes da Silva ; et al.

EClinicalMedicine, Vol 58, Iss , Pp 101939- (2023)

Schlagworte: Nirmatrelvir; SARS-CoV-2; Haematology; Malignancy; COVID-19; Medicine (General); R5-920
- View full text via DOI
Merkliste

15
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)

von Maria Stefania Infante ; Jon Salmanton-García ; Ana Fernández-Cruz ; et al.

Frontiers in Oncology, Vol 12 (2022)

Schlagworte: SARS-CoV-2; targeted drugs; infection risk; immune system COVID19; lymphoproliferative diseases (LPD); chronic lymphocytic leukemia (CLL); Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

16
Exome sequencing enables molecular diagnosis in 10% of early-onset or familial systemic lupus erythematosus cases

von Aeschlimann, Florence ; Allard, Lise ; Besson-Leaud, Laurent ; et al.

In eBioMedicine April 2026 126
- View full text via DOI
Merkliste

17
Outcome of COVID-19 in Patients With Mantle Cell Lymphoma—Report From the European MCL Registry

von Marie-Kristin Tilch ; Carlo Visco ; Sandra Kinda ; et al.

HemaSphere, Vol 6, Iss 5, p e0711 (2022)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

18
A third anti-SARS-CoV-2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia

von Milena Kohn ; Marc Delord ; Maureen Chbat ; et al.

Haematologica, Vol 107, Iss 6 (2021)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

19
It is time to adapt anti-CD20 administration schedules to allow efficient anti-SARS-CoV-2 vaccination in patients with lymphoid malignancies

von Caroline Besson

Haematologica, Vol 107, Iss 3 (2021)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

20
Highlights on the risk of pulmonary tuberculosis in patients on ibrutinib treatment: Case report and literature review

von Solo Traoré ; Mehdi Roumila ; Pirayeh Eftekhari ; et al.

eJHaem, Vol 1, Iss 2, Pp 601-603 (2020)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

21
Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study

von Sylvain Lamure ; Rémy Duléry ; Roberta Di Blasi ; et al.

EClinicalMedicine, Vol 27, Iss , Pp 100549- (2020)

Schlagworte: Medicine (General); R5-920
- View full text via DOI
Merkliste

22
Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma

von Christian W. Thorball ; Tiphaine Oudot-Mellakh ; Nava Ehsan ; et al.

Haematologica, Vol 106, Iss 8 (2020)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

23
HIGH PREVALENCE OF HEPATITIS C VIRUS ASSOCIATED B-CELL LYMPHOMA IN MANSOURA REGION (EGYPT), ANRS 12263 STUDY

von Layla M. Saleh ; Danielle Canioni ; Sameh Shamaa ; et al.

Mediterranean Journal of Hematology and Infectious Diseases, Vol 11, Iss 1, Pp e2019011-e2019011 (2019)

Schlagworte: HCV; Non-Hodgkin lymphoma; viremia; Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

24
Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages

von Driouich, Jean-Sélim ; Cochin, Maxime ; Lingas, Guillaume ; et al.

In Biomedicine & Pharmacotherapy August 2024 177
- View full text via DOI
Merkliste

25
Immune reconstitution and evolution of B-cell–stimulating cytokines after R-CHOP therapy for HIV-associated DLBCL

von Liévin, Raphaël ; Maillard, Alexis ; Hendel-Chavez, Houria ; et al.

In Blood Advances 10 December 2024 8(23):6017-6027
- View full text via DOI
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag